Navigation Links
Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler
Date:6/8/2009

ther products do, but instead uses natural sugar to improve durability. EVOLENCE(R) collagen is cross-linked through its patented GLYMATRIX(TM) Technology using the natural sugar, D-Ribose. The GLYMATRIX(TM) process is designed to:

  • Mimic naturally occurring collagen in the skin by creating a true structural framework with natural, durable cross-links to ensure filler longevity
  • Provide consistent and predictable results
  • Use natural ingredients for natural-looking results

The naturally sourced porcine collagen used in EVOLENCE(R) is the most genetically similar to human collagen and has been used safely and effectively for decades in various medical applications, including heart valve replacement.

This new generation collagen filler is intended for injection into the mid-to-deep dermis for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds. The most common side effects of EVOLENCE(R) injections are usually injection-site related and include mild swelling, redness, and pain. Other rare side effects include the development of small areas of firmness under the skin at the treated sites that may be noticed when the areas are pressed upon.

EVOLENCE(R) has undergone rigorous testing and has been demonstrated to be safe and effective through clinical studies. For more information on the product, visit www.evolence.com.

(1) "Twelve-Month Persistency of a Novel Ribose-Cross-linked Collagen Dermal Filler," Narins, R. et. al., Dermatol Surg 2008; 34; S31-S39

* Initial treatment is defined as a single treatment with the option of touch-up within two to three weeks to achieve optimal correction.

About Ortho Dermatologics:

EVOLENCE(R) is marketed in the United States by Ortho Derm
'/>"/>

SOURCE Ortho Dermatologics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Photos: Breakthrough Technology Enables Edible TruTag(TM) to Prevent Counterfeit Medicine
2. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
3. Photos: Project Runways Tim Gunn Launches Addressing Psoriasis(TM) Campaign to Advocate That Patients Shouldnt Let Psoriasis Impact Personal Style
4. FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD
5. FDA Approves Boston Scientifics Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
6. Arpida Annual General Meeting of Shareholders Approves All Board Proposals
7. Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
8. FDA Approves Label Change for Non-Invasive Fibroid Treatment
9. FDA Approves SyntheMeds REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
10. FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)
11. FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... CORALVILLE, Iowa , Sept. 30, 2014 /PRNewswire/ ... in the discovery and development of proprietary new ... United States Patent and Trademark Office (USPTO) issued ... patent application entitled, "Benzoic Acid, Benzoic Acid Derivatives ... Methods of Making and Use Thereof." ...
(Date:9/30/2014)... iLab Solutions announced the results of its ... on core facility operations, growth and utilization as well ... In its 4th year running, a number of long-term ... decrease in the percentage of revenue that comes from ... constraints of this trend. When asked, “What are your ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Lyme ... funder of Lyme disease research at universities, today announced ... focused on the identification, treatment and cure for Lyme ... had received the most applications in its history—over 20 ... , “While we were pleased to receive so many ...
(Date:9/30/2014)... September 30, 2014 On September 11, Pharma ... Sherley in anticipation of a session that he will lead ... Summit,” scheduled for February 17-18, 2015 in London. In ... IQ asked Dr. Sherley to respond to several questions on ... challenges to evaluating stem cell toxicity, and future trends in ...
Breaking Biology Technology:KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 4Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 2Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 4
... in the lower half of states in federal contracting ... researchers and companies land more federal security contracts. , ... a grant from the U.S. Small Business Administration ... classified research. , ,What we're trying to do is ...
... Madison, Wis. - Mirus Bio Corp. ... $900,000 to extend its microRNA detection technology for clinical ... life-science company engaged in gene therapy and the study ... National Institute of General Medical Sciences . It ...
... dependence on transportation infrastructure between Illinois and Wisconsin. ... and existing developments was highlighted. Building a true ... great supporting infrastructure, but I was surprised at ... Zielonka, a CPA, commented that the Chicago-Milwaukee connection ...
Cached Biology Technology:Research consortium aims to bring security and defense contracts to Wisconsin 2Mega-Metro Center may go beyond Chicago and Wisconsin 2Mega-Metro Center may go beyond Chicago and Wisconsin 3Mega-Metro Center may go beyond Chicago and Wisconsin 4Mega-Metro Center may go beyond Chicago and Wisconsin 5
(Date:9/30/2014)... almost any aquatic environment on Earth, but when the ... pushed to the limit. The amount of time needed ... how different species cope in the future, reveals a ... published in the scientific journal Proceedings of the ... thanks to increasing levels of greenhouse gases in the ...
(Date:9/30/2014)... in urban and farm runoff in Hawaii is causing ... , The study, published Tuesday in the peer-reviewed ... the runoff ends up in algae that the turtles ... eyes, flippers and internal organs. , Scientists at Duke ... and Atmospheric Administration (NOAA) conducted the study to better ...
(Date:9/30/2014)... (LMU) in Munich report that a new class ... to chemotherapeutic drugs. They have also pinpointed the ... for anti-tumor agents. , Researchers led by ... of the Technische Universitt Mnchen have identified a ... weapon in the fight against malignant tumors. The ...
Breaking Biology News(10 mins):Shape up quickly -- applies to fish, too! 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Cancer therapy: Driving cancer cells to suicide 2
... has found that protein and not sugar activates the ... The research, published in the 17 November issue ... for understanding obesity and sleep disorders. Wakefulness and ... stimulant called orexin/hypocretin in the brain. Reduced activity in ...
... the first time, researchers have identified two important ... involved in degrading persistent pollutants such as PCBs. ... of Centre INRSInstitut Armand-Frappier in conjunction with U.S. ... help develop effective biocatalysts for resolving environmental pollution ...
... In an irony of nature, invasive species can become ... according to a recent discovery that could change how ... Princeton University researchers report this month in the ... evidence that destructive, non-native animals that have been deservedly ...
Cached Biology News:3 p.m. slump? Why a sugar rush may not be the answer 2Harm not those strangers that pollinate, study warns 2Harm not those strangers that pollinate, study warns 3Harm not those strangers that pollinate, study warns 4